# Early Discontinuation of Empirical Antifungal Therapy and Biomarkers

> **NCT03538912** · NA · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 194 (estimated)

## Conditions studied

- Invasive Candidiasis

## Interventions

- **OTHER:** Biomarker strategy
- **OTHER:** Routine strategy

## Key facts

- **NCT ID:** NCT03538912
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-06
- **Primary completion:** 2024-06
- **Final completion:** 2025-06
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03538912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03538912, "Early Discontinuation of Empirical Antifungal Therapy and Biomarkers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03538912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*